Skip to content
10-Q

Quarterly Report

IRONWOOD PHARMACEUTICALS INC IRWD

0001104659-25-108795

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 162.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 177.76M sh
Shares Diluted Q3 2025 · Sep 30, 2025 177.06M sh
Shares Diluted Q3 2025 · Sep 30, 2024 160.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 158.81M sh
Capex Q3 2025 · Sep 30, 2025 $35K
Capex Q3 2025 · Sep 30, 2024 $142K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $52.47M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $88.34M
Long Term Debt Q3 2025 · Sep 30, 2025 $199.51M
Long Term Debt Q3 2025 · Dec 31, 2024 $198.99M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $140.41M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $88.56M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$264.16M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$301.34M
Current Liabilities Q3 2025 · Sep 30, 2025 $242.5M
Current Liabilities Q3 2025 · Dec 31, 2024 $38.85M
Current Assets Q3 2025 · Sep 30, 2025 $273.84M
Current Assets Q3 2025 · Dec 31, 2024 $182.37M
Total Assets Q3 2025 · Sep 30, 2025 $396.06M
Total Assets Q3 2025 · Dec 31, 2024 $350.91M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.23
Eps Diluted Q3 2025 · Sep 30, 2025 $0.16
Eps Diluted Q3 2025 · Sep 30, 2024 $0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.25
Eps Basic Q3 2025 · Sep 30, 2025 $0.16
Eps Basic Q3 2025 · Sep 30, 2024 $0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Sga Expense Q3 2025 · Sep 30, 2025 $21.91M
Sga Expense Q3 2025 · Sep 30, 2025 $62.96M
Sga Expense Q3 2025 · Sep 30, 2024 $36.11M
Sga Expense Q3 2025 · Sep 30, 2024 $110.68M
Rd Expense Q3 2025 · Sep 30, 2025 $22.47M
Rd Expense Q3 2025 · Sep 30, 2025 $73.27M
Rd Expense Q3 2025 · Sep 30, 2024 $29.83M
Rd Expense Q3 2025 · Sep 30, 2024 $86.03M
Net Income Q3 2025 · Sep 30, 2025 $40.08M
Net Income Q3 2025 · Sep 30, 2025 $26.29M
Net Income Q3 2025 · Sep 30, 2024 $3.65M
Net Income Q3 2025 · Sep 30, 2024 −$1.38M
Operating Income Q3 2025 · Sep 30, 2025 $75.48M
Operating Income Q3 2025 · Sep 30, 2025 $91.7M
Operating Income Q3 2025 · Sep 30, 2024 $25.64M
Operating Income Q3 2025 · Sep 30, 2024 $61.63M
Revenue Q3 2025 · Sep 30, 2025 $122.06M
Revenue Q3 2025 · Sep 30, 2025 $248.44M
Revenue Q3 2025 · Sep 30, 2024 $91.59M
Revenue Q3 2025 · Sep 30, 2024 $260.87M